USMD has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
USMD has been removed from your Stock Email Alerts list.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash to Debt | 0.259 |
USMD's Cash to Debt is ranked higher than
70% of the 220 Companies in the Global Medical Care industry. ( Industry Median: 0.19 vs. USMD: 0.259 ) |
USMD'
s 10-Year Cash to Debt Range
Min: 0.26 Max: 1.18 Current: 0.26 |
| Equity to Asset | 0.661 |
USMD's Equity to Asset is ranked higher than
77% of the 220 Companies in the Global Medical Care industry. ( Industry Median: 0.42 vs. USMD: 0.661 ) |
USMD'
s 10-Year Equity to Asset Range
Min: 0.38 Max: 0.66 Current: 0.66 |
| Z-Score: 2.47 |
|
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating margin (%) | 11.60 |
USMD's Operating margin (%) is ranked higher than
77% of the 220 Companies in the Global Medical Care industry. ( Industry Median: 8.00 vs. USMD: 11.60 ) |
USMD'
s 10-Year Operating margin (%) Range
Min: 11.6 Max: 38.2 Current: 11.6 |
| Net-margin (%) | 2 |
USMD's Net-margin (%) is ranked higher than
59% of the 220 Companies in the Global Medical Care industry. ( Industry Median: 3.40 vs. USMD: 2 ) |
USMD'
s 10-Year Net-margin (%) Range
Min: 2 Max: 13.3 Current: 2 |
| ROE (%) | 1.3 |
USMD's ROE (%) is ranked higher than
55% of the 220 Companies in the Global Medical Care industry. ( Industry Median: 7.60 vs. USMD: 1.3 ) |
USMD'
s 10-Year ROE (%) Range
Min: 1.3 Max: 53.6 Current: 1.3 |
| ROA (%) | 0.8 |
USMD's ROA (%) is ranked higher than
53% of the 220 Companies in the Global Medical Care industry. ( Industry Median: 3.00 vs. USMD: 0.8 ) |
USMD'
s 10-Year ROA (%) Range
Min: 0.8 Max: 20.1 Current: 0.8 |
| ROC (Joel Greenblatt) (%) | 34.10 |
USMD's ROC (Joel Greenblatt) (%) is ranked higher than
81% of the 220 Companies in the Global Medical Care industry. ( Industry Median: 15.60 vs. USMD: 34.10 ) |
USMD'
s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 34.1 Max: 545.9 Current: 34.1 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| P/E(ttm) | 291.60 |
USMD's P/E(ttm) is ranked lower than
71% of the 155 Companies in the Global Medical Care industry. ( Industry Median: 19.60 vs. USMD: 291.60 ) |
USMD'
s 10-Year P/E(ttm) Range
Min: 65.92 Max: 291.6 Current: 291.6 |
| P/B | 2.10 |
USMD's P/B is ranked higher than
79% of the 179 Companies in the Global Medical Care industry. ( Industry Median: 2.05 vs. USMD: 2.10 ) |
USMD'
s 10-Year P/B Range
Min: 0.31 Max: 2.1 Current: 2.1 |
| P/S | 1.70 |
USMD's P/S is ranked higher than
56% of the 198 Companies in the Global Medical Care industry. ( Industry Median: 1.06 vs. USMD: 1.70 ) |
USMD'
s 10-Year P/S Range
Min: 0.72 Max: 5.96 Current: 1.7 |
| PFCF | 499.90 |
USMD's PFCF is ranked lower than
68% of the 151 Companies in the Global Medical Care industry. ( Industry Median: 14.50 vs. USMD: 499.90 ) |
USMD'
s 10-Year PFCF Range
Min: 180.36 Max: 499.9 Current: 499.9 |
| EV-to-EBIT | 31.3 |
USMD's EV-to-EBIT is ranked higher than
50% of the 153 Companies in the Global Medical Care industry. ( Industry Median: 13.85 vs. USMD: 31.3 ) |
USMD'
s 10-Year EV-to-EBIT Range
Min: 5.6 Max: 21.1 Current: 31.3 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price/Net Current Asset Value | 159.1 |
USMD's Price/Net Current Asset Value is ranked lower than
93% of the 148 Companies in the Global Medical Care industry. ( Industry Median: 9.80 vs. USMD: 159.1 ) |
USMD'
s 10-Year Price/Net Current Asset Value Range
Min: 21.1 Max: 21.1 Current: 159.1 |
| Price/Tangible Book | 18.3 |
USMD's Price/Tangible Book is ranked lower than
85% of the 101 Companies in the Global Medical Care industry. ( Industry Median: 2.90 vs. USMD: 18.3 ) |
USMD'
s 10-Year Price/Tangible Book Range
Min: 2.4 Max: 2.4 Current: 18.3 |
| Price/Median PS Value | 2.2 |
USMD's Price/Median PS Value is ranked higher than
50% of the 176 Companies in the Global Medical Care industry. ( Industry Median: 1.10 vs. USMD: 2.2 ) |
USMD'
s 10-Year Price/Median PS Value Range
Min: 0.7 Max: 0.7 Current: 2.2 |
| Price/Graham Number | 2.6 |
USMD's Price/Graham Number is ranked higher than
53% of the 83 Companies in the Global Medical Care industry. ( Industry Median: 1.70 vs. USMD: 2.6 ) |
USMD'
s 10-Year Price/Graham Number Range
Min: 0.6 Max: 0.6 Current: 2.6 |
| Earnings Yield (Greenblatt) | 3.20 |
USMD's Earnings Yield (Greenblatt) is ranked higher than
63% of the 220 Companies in the Global Medical Care industry. ( Industry Median: 5.20 vs. USMD: 3.20 ) |
USMD'
s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.2 Max: 17.7 Current: 3.2 |
| Industry: | Medical Care |
|---|---|
| Compare: |